Three-quarters of pharmacies expect surge in demand for weight-loss pill National Pharmacy Association says the availability of oral semaglutide (Wegovy; Novo Nordisk) “is particularly significant for patients who cannot or do not want to take an injectable medicine”.…
Health news round-up: relabelling prostate cancer, zoonotic diseases and e-cigarette chemicals The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
Blood pressure and cholesterol in older adults with obesity found to be similar to people with healthy BMIs Study authors said their findings coincide with an increased use of cholesterol-lowering medication and blood pressure medication in recent years among adults aged over 40 years with obesity, compared with adults with normal BMIs.…
Community pharmacies receive government obesity care funding The announcement is part of a UK-wide programme of innovative schemes that could include the provision of weight-loss drugs.…
Health news round-up: contraception, obesity inequalities and eating disorders on GLP-1s The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
Pharmacy regulator warns against promotion of prescription weight-loss medicines A notice has reminded businesses that they cannot advertise prescription-only medicines or prescription-only medical treatments to the public.…
Health news round-up: endocrine research, binge eating on the pill and AI in the NHS The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
More than half of patients who stop weight-loss drugs restart within a year Researchers found that people taking newer medications, such as tirzepatide, were 41% less likely to discontinue than those taking older drugs, such as liraglutide.…
MHRA approves semaglutide oral tablets for weight loss The Medicines and Healthcare products Regulatory Agency advises that patients must start at the lowest 1.5mg daily dose of oral semaglutide tablets, which can be further increased to 4mg, 9mg and 25mg doses.…
Commissioning pharmacies would be ‘most effective way’ to meet weight-loss demand, MPs told Health and Social Care Committee hears that “further and faster” roll-out is required for weight-management service to prevent “two-tier” system between NHS and private patients.…
